These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1296536)
1. [Immunochemotherapy of infants in the first year of life with intestinal infections due to opportunistic gram-negative aerobic bacteria]. Litiaeva LA Antibiot Khimioter; 1992 Oct; 37(10):44-6. PubMed ID: 1296536 [TBL] [Abstract][Full Text] [Related]
2. [Antibiotic sensitivity of gram-negative opportunistic bacteria isolated from the feces of newborn infants with intestinal infections]. Litiaeva LA; Zakopaeva ES Antibiot Khimioter; 1989 Jan; 34(1):66-8. PubMed ID: 2730219 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of newborns with intestinal infections caused by opportunistic gram-negative aerobic bacteria]. Litiaeva LA Antibiot Khimioter; 1991 Sep; 36(9):37-8. PubMed ID: 1781711 [TBL] [Abstract][Full Text] [Related]
4. [Immunoglobulin efficacy for intravenous administration in the therapy of newborn infants with a suppurative infection]. Feklisova LV; Pokatilova AI; Iurina TM; Kiseleva IA; Shabalin VN Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):53-6. PubMed ID: 1882610 [TBL] [Abstract][Full Text] [Related]
6. Gut overgrowth with abnormal flora: the missing link in parenteral nutrition-related sepsis in surgical neonates. van Saene HK; Taylor N; Donnell SC; Glynn J; Magnall VL; Okada Y; Klein NJ; Pierro A; Lloyd DA Eur J Clin Nutr; 2003 Apr; 57(4):548-53. PubMed ID: 12700616 [TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of acipole in prevention of enteric dysbacteriosis due to antibacterial therapy]. Oleĭnichenko EV; Mitrokhin SD; Nonikov VE; Minaev VI Antibiot Khimioter; 1999; 44(1):23-5. PubMed ID: 10095921 [TBL] [Abstract][Full Text] [Related]
8. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants]. Kushnareva MV; Keshishian ES; Soboleva SV Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies. Morell A; Barandun S Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S87-91. PubMed ID: 2840630 [TBL] [Abstract][Full Text] [Related]
10. [The principles of the diagnosis of acute intestinal infections caused by opportunistic bacteria in children]. Bokovoĭ AG; Nisevich NI Pediatriia; 1992; (7-9):11-5. PubMed ID: 1475132 [TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia pneumonia in a premature infant. Ozkan H; Paşaoğlu G; Olgaç N; Günel R; Yüce A; Gülay Z Turk J Pediatr; 1999; 41(2):283-6. PubMed ID: 10770672 [TBL] [Abstract][Full Text] [Related]
12. Infections and immunodeficiency in bone marrow transplantation. Tutschka PJ Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S22-9. PubMed ID: 3041357 [TBL] [Abstract][Full Text] [Related]
13. [Role of microbiological surveillance in the choice of antibacterial therapy for intestinal Klebsiella infection in infants]. Martynenko LD; Vladimirova EV; Loverdo RG; Chertishcheva EV Antibiot Khimioter; 1990 Sep; 35(9):45-7. PubMed ID: 2275594 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics. Fischer GW; Weisman LE Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662 [TBL] [Abstract][Full Text] [Related]
16. [Immunologic correction with immunoglobulin of toxemia with exicosis in infants with acute intestinal infections]. Vereshchagin IA; Zhabotina LA Antibiot Khimioter; 1992 Apr; 37(4):41-3. PubMed ID: 1417316 [TBL] [Abstract][Full Text] [Related]
17. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Rolston KV Clin Infect Dis; 2005 Apr; 40 Suppl 4():S246-52. PubMed ID: 15768330 [TBL] [Abstract][Full Text] [Related]
18. [Prospects for designing immunoglobulins to prevent and treat purulent-inflammatory diseases]. Levina LA; Migunov VN; Temper RM Vestn Ross Akad Med Nauk; 1996; (8):26-31. PubMed ID: 8963191 [TBL] [Abstract][Full Text] [Related]
20. [Outlook for using bacteria of the genus Bacillus for the design of new biopreparations]. Sorokulova IB Antibiot Khimioter; 1996; 41(10):13-5. PubMed ID: 9027285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]